Alzheimer's - Nursing Case Study

Pathophysiology

• Primary mechanism: Accumulation of beta-amyloid plaques disrupts cell communication, leading to neuron damage and death. This extracellular deposition interferes with synaptic function, causing progressive cognitive decline.

• Secondary mechanism: Formation of neurofibrillary tangles composed of hyperphosphorylated tau proteins inside neurons. This disrupts the transport system and contributes to cell death and brain atrophy.

• Key complication: Neuronal loss and brain shrinkage, particularly in the hippocampus and cortex, lead to impaired memory, thinking, and behavior, which are hallmark symptoms of Alzheimer's disease.

Patient Profile

Demographics:

72-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Osteoarthritis

• Current medications: Donepezil, Metformin, Lisinopril, Acetaminophen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing memory loss and confusion

• Key symptoms: Difficulty with problem-solving, disorientation to time and place, changes in mood and behavior, difficulty completing familiar tasks

• Vital signs: Blood pressure 150/90 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

During a follow-up appointment, the patient's family expresses concern over her increasing disorientation and occasional episodes of agitation. The nurse conducts an initial assessment, noting that the patient is alert but confused about the date and location. She struggles to recall recent events and demonstrates difficulty with word-finding, suggesting a further decline in cognitive function. The patient's blood pressure remains elevated at 160/95 mmHg, and her heart rate has increased to 92 bpm, possibly indicating heightened anxiety or stress. Her oxygen saturation has slightly decreased to 92% on room air, warranting further investigation into potential respiratory complications.

Laboratory tests reveal a glycated hemoglobin (HbA1c) level of 7.8%, indicating suboptimal control of her Type 2 Diabetes, which may exacerbate her cognitive symptoms. Additionally, a recent MRI shows increased atrophy in the hippocampal region compared to previous imaging, correlating with her worsening memory issues. The neuroimaging findings, combined with the lab results, suggest a need for a reevaluation of her diabetes management and a potential adjustment in her Alzheimer's treatment plan.

The interdisciplinary team discusses possible interventions, considering the need to address her complex medical status. Adjustments to her antihypertensive and antidiabetic medications are considered to optimize cardiovascular and metabolic control. The team also evaluates the potential benefits of introducing a new cognitive-enhancing agent, while carefully monitoring for interactions with her existing medications. Family education is emphasized, focusing on managing her environment to reduce stressors that may trigger agitation, thereby improving her quality of life and potentially slowing cognitive decline.

Section 2

During a subsequent visit, the nurse observes a notable change in the patient's status. The patient exhibits increased episodes of agitation, particularly in the late afternoon, suggesting the onset of sundowning syndrome, a common complication in Alzheimer's disease. Her family reports that she has been wandering at night, raising concerns about her safety. Physically, she appears more fatigued, and her gait has become unsteady, increasing the risk of falls. Her vital signs reveal a persistent elevation in blood pressure at 162/98 mmHg and a further increase in heart rate to 98 bpm. Oxygen saturation remains borderline at 91% on room air, prompting consideration of underlying respiratory issues, possibly due to decreased mobility or undiagnosed sleep apnea.

In response to these changes, the interdisciplinary team reevaluates the patient's treatment strategy. A referral to a sleep specialist is recommended to assess for potential sleep disorders that may be contributing to her cognitive and behavioral symptoms. The patient's antihypertensive regimen is adjusted, adding a low-dose beta-blocker to address both her hypertension and tachycardia, while cautiously monitoring for effects on her respiratory status. Additionally, a low-dose antipsychotic is considered to help manage her agitation and wandering, with the understanding that its use will be closely monitored to avoid exacerbating her cognitive impairment.

Family education continues to be a priority, with the care team providing guidance on creating a safer home environment to prevent falls and minimize stressors that may trigger sundowning. Strategies include increased lighting in the evenings, establishing a regular bedtime routine, and removing potential trip hazards. The family is encouraged to maintain a log of the patient's behavioral patterns to assist in identifying triggers and evaluating the effectiveness of interventions. This comprehensive approach aims to stabilize the patient's condition and enhance her quality of life, while the team prepares to address potential future complications.

Section 3

As the care plan is implemented, the patient's family diligently follows the team's recommendations to create a safer environment and maintain a log of her behaviors. During a follow-up visit two weeks later, the nurse conducts an initial assessment to gauge the effectiveness of the interventions. The patient's vital signs show some improvement; her blood pressure has decreased slightly to 150/92 mmHg, and her heart rate is steady at 88 bpm. Oxygen saturation, however, remains at 91% on room air. Her family reports that the patient's episodes of agitation have lessened in intensity, although they still occur. The wandering at night has decreased, attributed to the newly established bedtime routine, but she continues to exhibit signs of fatigue during the day.

The patient's gait remains unsteady, with a recent incident where she nearly fell in the bathroom, highlighting the ongoing risk of falls. Physical examination reveals mild weakness in her lower extremities, which may be contributing to her instability. The family expresses concern about her reduced mobility, especially since she is spending more time resting during the day. The sleep specialist's evaluation results indicate the presence of moderate obstructive sleep apnea, likely exacerbating her fatigue and cognitive difficulties. A continuous positive airway pressure (CPAP) therapy is recommended to improve her sleep quality and potentially enhance her overall function.

The care team discusses these findings with the family, emphasizing the importance of adhering to CPAP therapy and considering physical therapy to strengthen her muscles and improve balance. They also stress the need for ongoing monitoring of her blood pressure and heart rate, as well as reviewing the effectiveness of the antipsychotic medication in reducing agitation without causing undue sedation. As the team continues to address these intertwined health issues, they prepare to tackle potential complications, such as the risk of recurrent infections due to decreased mobility, while focusing on strategies that promote the patient's safety and well-being.

Section 4

Two weeks following the implementation of CPAP therapy and the initiation of physical therapy, the patient returns for another follow-up visit. Her family reports adherence to CPAP, noting a slight improvement in her sleep quality, as evidenced by fewer awakenings during the night. However, the patient now exhibits increased daytime confusion and mild disorientation, especially in the morning hours. This change prompts a thorough review of her medication regimen and sleep patterns. During the assessment, her vital signs reveal a stable blood pressure at 148/90 mmHg and a heart rate of 84 bpm. Her oxygen saturation has improved to 93% on room air, indicating a positive response to CPAP. However, her cognitive status presents a new challenge.

Physical examination continues to show mild weakness in the lower extremities, but there is encouraging progress in muscle strength due to physical therapy sessions. Despite these gains, her gait remains unsteady, and the fall risk persists. The interdisciplinary team considers whether the antipsychotic medication may be contributing to her morning confusion and contemplates adjusting the dosage or timing to better align with her circadian rhythm. Additionally, the family mentions a recent urinary tract infection, which potentially exacerbates her confusion and highlights the need for vigilant infection prevention strategies.

With these developments, the care team emphasizes the importance of maintaining a balance between managing her agitation and minimizing side effects from medications. They advise the family to ensure consistent hydration and monitor for signs of infection. As they continue to refine her care plan, the team plans to reassess the impact of these interventions on her cognitive function and overall mobility, preparing to address any further complications that may arise in this complex clinical picture.

Section 5

New Complications:

Upon further evaluation of the patient's cognitive status, the healthcare team identifies that the morning confusion and disorientation may be linked to the recent urinary tract infection (UTI). A urinalysis conducted during the follow-up visit confirms the presence of nitrites and leukocyte esterase, suggesting persistent infection despite prior antibiotic treatment. The patient's lab results show a mild leukocytosis with a white blood cell count of 11,500/mm³, consistent with an ongoing inflammatory response. This finding prompts the team to consider the possibility of antibiotic resistance or inadequate initial treatment. The interdisciplinary team decides to initiate a different antibiotic regimen tailored to the sensitivities of the cultured bacteria, aiming to effectively eradicate the infection and potentially reduce the cognitive disturbances.

Simultaneously, the review of the patient's medication regimen reveals that the timing of her antipsychotic medication may be contributing to her morning confusion. The team decides to adjust the administration time to align better with her sleep-wake cycle, hoping to mitigate any adverse effects on her cognition. The family is educated on recognizing early signs of infection and the importance of completing the full course of antibiotics. Additionally, they are encouraged to continue supporting the patient's hydration and nutrition, which are critical in preventing further UTIs and promoting overall health. These adjustments aim to stabilize her cognitive status and prevent further complications, setting the stage for subsequent evaluations of her progress and response to the interventions. The care team plans to closely monitor the patient over the coming weeks to assess the efficacy of these changes and make further adjustments as necessary.